Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCastelo-Branco, L.
dc.contributor.authorAwada, Ahmad
dc.contributor.authorPentheroudakis, G.
dc.contributor.authorPerez-Gracia, J. L.
dc.contributor.authorMateo Valderrama, Joaquim
dc.contributor.authorCurigliano, Giuseppe
dc.contributor.authorTabernero Caturla, Josep
dc.date.accessioned2022-04-22T12:58:05Z
dc.date.available2022-04-22T12:58:05Z
dc.date.issued2021-10
dc.identifier.citationCastelo-Branco L, Awada A, Pentheroudakis G, Perez-Gracia JL, Mateo J, Curigliano G, et al. Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology. ESMO Open. 2021 Oct;6(5):100237.
dc.identifier.issn2059-7029
dc.identifier.urihttp://hdl.handle.net/11351/7372
dc.descriptionCOVID-19 pandemic; Oncology
dc.description.abstractIn this paper, we aim to capitalize on the lessons learnt from the impact of the COVID-19 pandemic on clinical trials and use them as a catalyst to launch a discussion over a framework of broader adaptations needed in the design and implementation of oncology clinical trials
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesESMO Open;6(5)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectOncologia
dc.subjectPandèmia de COVID-19, 2020-
dc.subjectAssaigs clínics
dc.subject.meshCoronavirus Infections
dc.subject.meshMedical Oncology
dc.subject.meshClinical Trial
dc.titleBeyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.esmoop.2021.100237
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsoncología médica
dc.subject.decsensayo clínico
dc.relation.publishversionhttps://doi.org/10.1016/j.esmoop.2021.100237
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Castelo-Branco L, Pentheroudakis G] Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland. [Awada A] Head of the Oncology Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Belgium. [Perez-Gracia JL] Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain. [Mateo J] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Curigliano G] Istituto Europeo di Oncologia, IRCCS and University of Milano, Milano, Italy. [Tabernero J] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Spain
dc.identifier.pmid34411971
dc.identifier.wos000704803800035
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record